Volume 4, Issue 4: Christine Cooper, CEO, aequum LLC Discusses Implications of the Medical Debt Cancellation Act

Dear Colleagues, I am excited to share my article titled, “Cash-Pay Options for Self-Insured Employers” in October’s issue of the The Self Insurer. As the title suggests, in this article, we will discuss the different ways cash-pay options benefit employers and self-insurers such as streamlining the administrative process of healthcare payments,

Industry News: Volume 4, Issue 4

Some doctors are using public AI chatbots like ChatGPT in clinical decisions. Is it safe? By Anastassia Gliadkovskaya fiercehealthcare.com - Nineteen-year-old Lia was at a follow-up appointment at a boutique dermatology practice in New York City. She was interested in a prescription for hair growth. Since she was already on another medication,

Volume 4, Issue 3: Will Clower, MD, Founder and CEO, Mediterranean Wellness, Discusses Long-Term Effectiveness of the Mediterranean Diet

Dear Colleagues, The Mediterranean diet and weight loss drugs – which approach is more effective for weight loss management? While both are effective approaches, the Mediterranean diet offers sustained health benefits including improved cardiovascular health, cognitive function and mental well-being. Weight loss drugs, on the other hand, can yield short-term results

Industry News: Volume 4, Issue 3

AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the launch of its podcast; AscellaHealth Podcast Pulse. This diverse new series dives deep into key

Volume 4, Issue 2: Armando Polanco, CEO, Apollo Vanguard Discusses International Solutions to Accessible, Low Cost and Quality Healthcare

Dear Colleagues, I am excited to bring you my article titled, “Cost Management Strategies for Chronic Diseases” in this month’s issue of the The Self Insurer. In this article, we will discuss the growing prevalence of chronic diseases in working Americans and the leading strategies for managing the costs such as

Spotlight Interview: Armando Polanco, CEO, Apollo Vanguard

About Armando Polanco, CEO Armando is also the CEO of Apollo Vanguard that offers three main services which include medical tourism of 13 years, prescription outsourcing program and pharmacogenomics, which entails genetic testing to identify drug interactions with patients. These services are offered within self-insured health programs to provide valued options

Industry News: Volume 4, Issue 2

Doctors draw attention to safety issues associated with popular weight-loss drugs By Daniella Genovese   foxbusiness.com - The demand for highly sought-after weight-loss drugs continues to rise. However, as more patients embrace this trend, doctors are cautioning them about potential side effects. Anti-obesity medications "exert potent effects throughout the body, particularly the gastrointestinal tract," according